Author(s): Ibrahim Alissa, Abdullah Alotaibi, Malak Aldossari, Hussein Alhelal, Nagaraja Sreeharsha


DOI: 10.52711/0974-360X.2021.00879   

Address: Ibrahim Alissa1*, Abdullah Alotaibi1, Malak Aldossari1, Hussein Alhelal1, Nagaraja Sreeharsha2,3
1Department of Pharmaceutical, Prince Sultan Cardiac Center, AL Ahsa - 31982, Saudi Arabia.
2Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa - 31982, Saudi Arabia.
3Department of Pharmaceutics, Vidya Siri College of Pharmacy, Off Sarjapura Road, Bengaluru - 560035, Karnataka, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 9,     Year - 2021

Inpatients managed in cardiology units have shown high risks of encouraging drug-related adverse reactions. This is coupled with the influx of diuretics and cardioprotective drug mechanism. The support played by a clinical pharmacist in this context remains largely underscored cored. They play an essential role in supporting the overall pharmacological care for patients through clinical conditions evaluations and assessments. Further, it has been established that poor adherence to drug regimens is among the key exacerbating factors for heart failure occurrence. The need for conducting patient education process is essential in drug adherence process. This elevates the roles of clinical pharmacist in the care delivery through drug use optimization process, minimization of occurrence of adverse drug events and activities in the transitional care process with a key focus on medical reconciliation approaches in the care practice. This study has focused on systematic reviews, Meta-analysis and randomized controlled studies focusing on the pharmacist intervention in improving outcomes of cardiology patients in the hospital care settings. The results have demonstrated that their role can no longer be underestimated and play an important role in the care delivery process and reducing the overall drug-related complications in the care process.

Cite this article:
Ibrahim Alissa, Abdullah Alotaibi, Malak Aldossari, Hussein Alhelal, Nagaraja Sreeharsha. The Roles of Pharmacists in Cardiac Care units in Hospitals. Research Journal of Pharmacy and Technology. 2021; 14(9):5039-6. doi: 10.52711/0974-360X.2021.00879

Ibrahim Alissa, Abdullah Alotaibi, Malak Aldossari, Hussein Alhelal, Nagaraja Sreeharsha. The Roles of Pharmacists in Cardiac Care units in Hospitals. Research Journal of Pharmacy and Technology. 2021; 14(9):5039-6. doi: 10.52711/0974-360X.2021.00879   Available on:

1.    Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW. Adverse drug events in ambulatory care. New England Journal of Medicine. 2003 Apr 17; 348(16): 1556-64.
2.    Guthrie B. H.R.592 - Pharmacy and Medically Underserved Areas Enhancement Act. 2015. Available at: Accessed September 17, 2015.
3.    Pharmacy A. The definition of clinical pharmacy. Pharmacotherapy. 2008; 28(6): 816-7.
4.    Kuo GM, Touchette DR, Marinac JS, American College of Clinical Pharmacy Practice‐Based Research Network Collaborative. Drug Errors and Related Interventions Reported by U nited S tates Clinical Pharmacists: The A merican C ollege of C linical P harmacy P ractice‐B ased R esearch N etwork M edication E rror D etection, A melioration and P revention Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2013 Mar; 33(3): 253-65.
5.    Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Archives of Internal Medicine. 1999 Sep 13; 159(16): 1939-45.
6.    Cheng JW, Cooke-Ariel H. Pharmacists’ role in the care of patients with heart failure: review and future evolution. Journal of Managed Care Pharmacy. 2014 Feb; 20(2): 206-13.
7.    Merenich JA, Olson KL, Delate T, Rasmussen J, Helling DK, Ward DG, Clinical Pharmacy Cardiac Risk Service Study. Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2007 Oct; 27(10): 1370-8.
8.    Sandhoff BG, Nies LK, Olson KL, Nash JD, Rasmussen JR, Merenich JA. Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization. American journal of health-system pharmacy. 2007 Jan 1; 64(1): 77-84.
9.    Ripley TL, Adamson PB, Hennebry TA, Van Tuyl JS, Harrison DL, Rathbun RC. Collaborative practice model between cardiologists and clinical pharmacists for management of patients with cardiovascular disease in an outpatient clinic. Annals of Pharmacotherapy. 2014 Mar; 48(3): 412-9.
10.    Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, Bosworth HB, Radcliff T, Davis R, Mun H, Weaver J. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Internal Medicine. 2014 Feb 1; 174(2): 186-93.
11.    Swieczkowski D, Merks P, Gruchala M, Jaguszewski MJ. The role of the pharmacist in the care of patients with cardiovascular diseases. Kardiol Pol. 2016 Jan 1; 74(11): 1319-26.
12.    Trillo Alonso F, Porto Tan E, Stewart K, Elliott R, George J. Pharmacists services provided in general practice clinics: A systematic review and meta-analysis.[Servicos farmacéuticos brindados en clìnicas de práctica general: Una revisión y metaanálisis]. Research in Social and Administrative Pharmacy. 2014; 10(4): 608-22.
13.    Rotta I, Salgado TM, Silva ML, Correr CJ, Fernandez-Llimos F. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010). International Journal of Clinical Pharmacy. 2015 Oct 1; 37(5): 687-97.
14.    Iyer S, Saunders WB, Stemkowski S. Economic burden of postoperative ileus associated with colectomy in the United States. Journal of Managed Care Pharmacy. 2009 Jul; 15(6): 485-94.
15.    Gleason KM, Groszek JM, Sullivan C, Rooney D, Barnard C, Noskin GA. Reconciliation of discrepancies in medications histories and admission orders of newly hospitalized patients. Am J Health Syst Pharm. 2004; 61(16: 1689–1695.
16.    Eggink RN, Lenderink AW, Widdershoven JW, van den Bemt PM. The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure. Pharm World Sci. 2010; 32(6): 759–766.
17.    Kripalani S, Roumie CL, Dalal AK, et al; PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012; 157(1): 1–10
18.    Fonarow GC, Yancy CW, Heywood JT; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Adherence to heart failure quality-of-care indicators in U.S. hospitals: analysis of the ADHERE registry. Arch Intern Med. 2005; 165(13): 1469–1477
19.    Roblek T, Deticek A, Leskovar B, et al. Clinical pharmacist intervention reduces clinically relevant drug–drug interactions in patients with heart failure: a randomized, double-blind controlled trial. Int J Cardiol. 2016; 203: 647–652.
20.    Dempsey JT, Matta LS, Carter DM, et al. Assessment of drug therapy-related issues in an outpatient heart failure population and the potential impact of pharmacist-driven intervention. J Pharm Pract. 2017; 30(3): 318–323.
21.    Ryan R, Santesso N, Hill S, Lowe D, Kaufman C, Grimshaw J. Consumer-oriented interventions for evidence based prescribing and medicines use: an overview of systemic reviews. Cochrane Database Syst Rev. 2011; 5: CD007768
22.    Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients’ clinical condition in heart failure? Br J Clin Pract. 1995; 49(4): 173–176.
23.    Varma S, Mc Elnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999; 19(7): 861–869
24.    Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to a heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999; 159(16): 1939–1945
25.    Whellan DJ, Gaulden L, Gattis WA, et al. The benefit of implementing a heart failure disease management program. Arch Intern Med. 2001; 161(18): 2223–2228
26.    Lowrie R, Mair FS, Greenlaw N, et al; Heart Failure Optimal Outcomes from Pharmacy Study (HOOPS) Investigators. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2012; 33(3): 314–324.
27.    Gwadry-Sridhar FH, Arnold JM, Zhang Y, Brown JE, Marchiori G, Guyatt G. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J. 2005; 150(5): 982
28.    Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008; 168(7): 687–694
29.    Kang JE, Han NY, Oh JM, et al. Pharmacist-involved care for patients with heart failure and acute coronary syndrome: a systematic review with qualitative and quantitative meta-analysis. J Clin Pharm Ther. 2016; 41(2): 145–157
30.    Cai H, Dai H, Hu Y, Yan X, Xu H. Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. BMC Health Services Research. 2013 Dec 1; 13(1): 461.
31.    Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. Journal of Managed Care Pharmacy. 2013 Jun; 19(5): 408-16.
32.    Rotta I, Souza TT, Salgado TM, Correr CJ, Fernandez-Llimos F. Characterization of published randomized controlled trials assessing clinical pharmacy services around the world. Research in Social and Administrative Pharmacy. 2017 Jan 1; 13(1): 201-8.
33.    Bruns W. Implications of an intracorporeal glucose sensor in the management of diabetic patients. Biomedica Biochimica Acta. 1989; 48(11-12): 925-33.
34.    Ryder M, Murphy NF, McCaffrey D, O’Loughlin C, Ledwidge M, McDonald K. Outpatient intravenous diuretic therapy: potential for marked reduction in hospitalization for acute decompensated heart failure. Eur J Heart Fail. 2008; 10(3): 267–272.
35.    Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Review of Cardiovascular Therapy. 2015 Feb 1; 13(2): 209-21.
36.    Pawłowska I, Pawłowski L, Kocić I, Krzyżaniak N. Clinical and conventional pharmacy services in Polish hospitals: a national survey. International Journal of Clinical Pharmacy. 2016 Apr 1; 38(2): 271-9.
37.    Louzon P, Jennings H, Ali M, Kraisinger M. Impact of pharmacist management of pain, agitation, and delirium in the intensive care unit through participation in multidisciplinary bundle rounds. American Journal of Health-System Pharmacy. 2017 Feb 15; 74(4): 253-62.
38.    Sakeena MH, Bennett AA, McLachlan AJ. Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review. Antimicrobial Resistance & Infection Control. 2018 Dec; 7(1): 1-1.
39.    Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: role of the pharmacist in risk assessment, prevention and management. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada. 2016 May; 149(3): 139-52.
40.    Beardsley JR, Jones CM, Williamson J, Chou J, Currie-Coyoy M, Jackson T. Pharmacist involvement in a multidisciplinary initiative to reduce sepsis-related mortality. American Journal of Health-System Pharmacy. 2016 Feb 1; 73(3): 143-9.
41.    Mekonnen AB, McLachlan AJ, Jo-anne EB. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016 Feb 1; 6(2).
42.    Chevalier BA, Watson BM, Barras MA, Cottrell WN. Hospital pharmacists' perceptions of medication counseling: A focus group study. Research in Social and Administrative Pharmacy. 2016 Sep 1; 12(5): 756-71.
43.    Jacobi J. Clinical pharmacists: practitioners who are essential members of your clinical care team. Revista Médica Clínica Las Condes. 2016 Sep 1; 27(5): 571-7.
44.    Irwin AN, Ham Y, Gerrity TM. Expanded roles for pharmacy technicians in the medication reconciliation process: a qualitative review. Hospital Pharmacy. 2017 Jan; 52(1): 44-53.
45.    Béchet C, Pichon R, Giordan A, Bonnabry P. Hospital pharmacists seen through the eyes of physicians: qualitative semi-structured interviews. International Journal of Clinical Pharmacy. 2016 Dec 1; 38(6): 1483-96.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available